MRK - Merck Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Company Name or Ticker Symbol

Search for other Categories

Merck & Co., Inc. (MRK)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Price: $74.7300 $0.13

0.174%

Day's High:	$75.11	Week Perf:	1.1 %
Day's Low:	$ 73.98	30 Day Perf:	-9.25 %
Volume (M):	12,194	52 Wk High:	$ 83.85
Volume (M$):	$ 911,235	52 Wk Avg:	$70.98
Open:	$74.73	52 Wk Low:	$56.26

MRK Charts & Quotes

MRK Charts & Quotes

Description of Company's Segments

Market Capitalization (Millions $)	195,602
Shares Outstanding (Millions)	2,617
Employees	70,000
Revenues (TTM) (Millions $)	42,294
Net Income (TTM) (Millions $)	6,193
Cash Flow (TTM) (Millions $)	0
Capital Exp. (TTM) (Millions $)	2,615

Merck & Co., Inc.
Merck & Co., Inc., is a global research-driven pharmaceutical products company that discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. The Company sells its products primarily to drug wholesalers and retailers, hospitals, clinics, government agencies and managed health care providers such as health maintenance organizations and other institutions. The Company’s professional representatives communicate the effectiveness, safety and value of its products to health care professionals in private practice, group practices and managed care organizations.

MRK is expected to report next financial results on April 29, 2019.

Merck's Segments


Zocor	Segment	0.57 %	of total Revenue
Zetia	Segment	6.48 %	of total Revenue
CozaarHyzaar	Segment	1.54 %	of total Revenue
Singulair	Segment	2.06 %	of total Revenue
Proscar	Segment	0.42 %	of total Revenue
Isentress	Segment	3.86 %	of total Revenue
Primaxin	Segment	0.77 %	of total Revenue
Remicade	Segment	4.52 %	of total Revenue
Januvia	Segment	10.38 %	of total Revenue
Cancidas	Segment	1.42 %	of total Revenue
Other	Segment	59.33 %	of total Revenue
Merck Pharmaceutical	Segment	91.34 %	of total Revenue
Vaccines	Segment	11.28 %	of total Revenue
All Other	Segment	8.66 %	of total Revenue

• View Complete Report

	Company Estimates
	• Revenue Outlook Merck announced annual revenue outlook on Jul. 28, 2015 • Earnings Outlook Merck & Co., Inc. issued annual earnings guidance on Jul. 28, 2015

Geographic Revenue Dispersion
United States	40.42 %
EMEA	31.19 %
Japan	8.22 %
Other	3.36 %
Asia Pacific	9.35 %
Latin America	7.46 %

News

Transportation & Logistics Systems, Inc.

EPS $2.2312997032604,

In the forth quarter Transportation & Logistics Systems, Inc eps at $2.23 per share, compare to results of $ per share a year ago quarter, In the previous quarter company realized $-13.89 per share.

Gsrx Industries Inc.

Gsrx Industries Inc announced forth quarter operating deficit of $-2.806165 millions

In the forth quarter Gsrx Industries Inc posted loss of $-0.06 per share compare to $0.32 a year ago and increased losses from $-0.04 per share from the previous quarter.

Sales remained unchanged to $1.66 millions from $0.00 millions in the same quarter a year ago and sequentially Sales doubled by 150.08 % from $0.66 millions.

Marimed Inc.

Marimed Inc announced forth quarter operating shortfall of $-7.314344 millions

Despite very strong Sales growth of 117.67 % year on year to $3.44 millions in the forth quarter, company faced turn a round at $0.02.

Adm Endeavors, Inc.

Break-even, Sales more than Double

In the forth quarter reached break-even of $-0.00 per share compare to $-0.00 a year ago and from $0.00 per share from the previous quarter.

Sales increased sharply by 10484.59 % to $1.57 millions from $0.01 millions in the same quarter a year ago and sequentially Sales advanced by 9.83 % from $1.43 millions.

Prolung Inc

Logged a Loss but Revenues Unchanged

In the forth quarter Prolung Inc lost money of $-0.87 per share compare to $-2.00 a year ago and increased losses from $-0.26 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

MRK's Valuation	Current
Price to Earnings PE Ratio (TTM)	32.10
Price to Earnings PE Ratio (Expected)	46.27
Price to Sales (TTM)	4.62
Price to Sales (Expected)	5.01
Price to Book	7.28
PEG (TTM)	0.19

MRK's Financial Strength	Current
Quick Ratio	0.4
Working Capital Ratio	1.17
Leverage Ratio (MRQ)	2.02
Total Debt to Equity	0.93
Interest Coverage (TTM)	-
Debt Coverage (TTM)	0.55

Per Share	Current
Earnings (TTM)	2.33 $
Revenues (TTM)	16.16 $
Cash Flow (TTM)	0 $
Cash	3.39 $
Book Value	10.27 $
Dividend (TTM)	1.93 $

MRK's Efficiency	Current
Revenue per Employee (TTM)	604,200
Net Income per Employee (TTM)	88,471
Receivable Turnover Ratio (TTM)	5.84
Inventory Turnover Ratio (TTM)	2.52
Asset Turnover Ratio (TTM)	0.5

MRK's Profitability Ratio	Current
Gross Margin	70.09 %
Operating Margin	24.68 %
Net Margin	16.17 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	28.82 %

Management Effectiveness	Current
Return On Assets (TTM)	7.31 %
Return On Investment (TTM)	9.69 %
Return On Equity (TTM)	19.63 %
Dividend Yield	2.61 %
Payout Ratio (TTM)	82.9 %

MRK's Valuation
Price to Earnings PE Ratio (TTM)	32.10
Price to Earnings PE Ratio (Expected)	46.27
Price to Sales (TTM)	4.62
Price to Sales (Expected)	5.01
Price to Book	7.28
PEG (TTM)	0.19

MRK's Financial Strength
Quick Ratio	0.4
Working Capital Ratio	1.17
Leverage Ratio (MRQ)	2.02
Total Debt to Equity	0.93
Interest Coverage (TTM)	-
Debt Coverage (TTM)	0.55

Per Share
Earnings (TTM)	2.33 $
Revenues (TTM)	16.16 $
Cash Flow (TTM)	0 $
Cash	3.39 $
Book Value	10.27 $
Dividend (TTM)	1.93 $

• View Valuation Comparisons

• View Growth Rates Comparisons

MRK's Efficiency
Revenue per Employee (TTM)	604,200
Net Income per Employee (TTM)	88,471
Receivable Turnover Ratio (TTM)	5.84
Inventory Turnover Ratio (TTM)	2.52
Asset Turnover Ratio (TTM)	0.5

MRK's Profitability Ratio
Gross Margin	70.09 %
Operating Margin	24.68 %
Net Margin	16.17 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	28.82 %

Management Effectiveness
Return On Assets (TTM)	7.31 %
Return On Investment (TTM)	9.69 %
Return On Equity (TTM)	19.63 %
Dividend Yield	2.61 %
Payout Ratio (TTM)	82.9 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income fell by	MRK's customers Net margin fell to 16.17 %
-35.1 %	3.6 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

You need to upgrade your Flash Player

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

BMY	-3.04%
CELG	-1.53%
JNJ		0.85%
ABT		0.48%
PFE	-3.79%
ABBV	-1.92%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar CENB's Profile Stock Price CENB's Financials Business Description Fundamentals Charts & Quotes CENB's News Suppliers CENB's Competitors Customers & Markets Economic Indicators CENB's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

MRK Company Profile

EPS $2.2312997032604,

Gsrx Industries Inc announced forth quarter operating deficit of $-2.806165 millions

Marimed Inc announced forth quarter operating shortfall of $-7.314344 millions

Break-even, Sales more than Double

Logged a Loss but Revenues Unchanged